Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Published:2020 Issue:7-8 Volume:104 Page:533-541
ISSN:0042-1138
Container-title:Urologia Internationalis
language:en
Short-container-title:Urol Int

Author:

Shen Maolei,Chen Guang,Xie Qiang,Li Xin,Xu Hao,Wang Hui,Zhao Shankun^ORCID

Publisher

S. Karger AG

Subject

Urology

Reference39 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2018;65(2):87–108.

2. Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810.

3. Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register. Scand J Urol. 2014;48(3):231–8.

4. Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28:62–79.

5. Fisher R, Gore M, Larkin J. Current and future systemic treatments for renal cell carcinoma. Semin Cancer Biol. 2013;23(1):38–45.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma;World Journal of Urology;2024-01-20

2. Discriminant Radiomic Feature Selection for PD-L1 Prediction in Clear Cell Renal Cell Carcinoma;2023 19th International Symposium on Medical Information Processing and Analysis (SIPAIM);2023-11-15

3. Efficacy and Safety of Anti-PD-1/PD-L1 Antibodies in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma: A Meta-Analysis;J BIOL REG HOMEOS AG;2023

4. Effect of CD274 (PD-L1) overexpression on survival outcomes in 10 specific cancers: a systematic review and meta-analysis;Journal of Clinical Pathology;2023-05-02

5. Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma;Current Oncology Reports;2023-03-31